Evidence map›Paper›PMID 37192155›Full record

ArticlePloS one2023

Field-deployable multiplex detection method of SARS-CoV-2 and influenza virus using loop-mediated isothermal amplification and DNA chromatography.

Kyoko Hayashida, Alejandro Garcia, Lavel Chinyama Moonga, Tatsuki Sugi, Kodera Takuya, Mitsuo Kawase, Fumihiro Kodama, Atsushi Nagasaka, Nobuhisa Ishiguro, Ayato Takada and 8 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 4 countries.

Kyoko HayashidaInternational Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.ORCID 0000-0001-9266-5162
Alejandro GarciaUCD Centre for Experimental Pathogen Host Research, University College Dublin, Belfield, Ireland.
Lavel Chinyama MoongaInternational Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Tatsuki SugiInternational Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Kodera TakuyaTBA Co., LTD, Sendai, Japan.
Mitsuo KawaseTBA Co., LTD, Sendai, Japan.
Fumihiro KodamaSapporo City General Hospital, Sapporo, Japan.
Atsushi NagasakaSapporo City General Hospital, Sapporo, Japan.
Nobuhisa IshiguroDivision of Infection Control, Hokkaido University Hospital, Sapporo, Japan.ORCID 0000-0001-8594-6345
Ayato TakadaInternational Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Masahiro KajiharaInternational Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Naganori NaoInternational Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Masashi ShingaiInternational Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Hiroshi KidaInternational Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Yasuhiko SuzukiInternational Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.ORCID 0000-0002-1313-1494
William W HallInternational Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Hirofumi SawaInternational Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Junya YamagishiInternational Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.ORCID 0000-0002-8385-5359
Hokkaido University · JPSapporo University · JPPenta-Ocean Construction (Japan) · JPSapporo City General Hospital · JPUniversity College Dublin · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel multiplex loop-mediated isothermal amplification (LAMP) method combined with DNA chromatography was developed for the simultaneous detection of three important respiratory disease-causing viruses: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A virus, and influenza B virus. Amplification was performed at a constant temperature, and a positive result was confirmed by a visible colored band. An in-house drying protocol with trehalose was used to prepare the dried format multiplex LAMP test. Using this dried multiplex LAMP test, the analytical sensitivity was determined to be 100 copies for each viral target and 100-1000 copies for the simultaneous detection of mixed targets. The multiplex LAMP system was validated using clinical COVID-19 specimens and compared with the real-time qRT-PCR method as a reference test. The determined sensitivity of the multiplex LAMP system for SARS-CoV-2 was 71% (95% CI: 0.62-0.79) for cycle threshold (Ct) ≤ 35 samples and 61% (95% CI: 0.53-0.69) for Ct ≤40 samples. The specificity was 99% (95%CI: 0.92-1.00) for Ct ≤35 samples and 100% (95%CI: 0.92-1.00) for the Ct ≤40 samples. The developed simple, rapid, low-cost, and laboratory-free multiplex LAMP system for the two major important respiratory viral diseases, COVID-19 and influenza, is a promising field-deployable diagnosis tool for the possible future 'twindemic, ' especially in resource-limited settings.

Indexed as

COVID-19OrthomyxoviridaeDNAHumansMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesRNA, ViralSARS-CoV-2Sensitivity and SpecificityDNARNA, Viral

Identifiers

PMID37192155
PMCPMC10187927
OpenAlexW4376872061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.